Inovio Pharmaceuticals
INO
#9666
Rank
A$0.16 B
Marketcap
A$1.57
Share price
-5.63%
Change (1 day)
-56.85%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): A-$2.75

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$2.63. In 2025 the company made an earnings per share (EPS) of A-$2.60 an increase over its 2024 EPS that were of A-$5.68.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.755.71%
2025A-$2.60-54.18%
2024A-$5.68-35.14%
2023A-$8.75-56.62%
2022A-$20.17-19.54%
2021A-$25.0735.9%
2020A-$18.45-11.57%
2019A-$20.8615.24%
2018A-$18.10-2.78%
2017A-$18.626.93%
2016A-$17.41134.88%
2015A-$7.41-29.51%
2014A-$10.52-57.34%
2013A-$24.66146.55%
2012A-$10.0020.83%
2011A-$8.28-29.41%
2010A-$11.72-48.48%
2009A-$22.7610%
2008A-$20.6911.11%
2007A-$18.62-41.3%
2006A-$31.72-66.91%
2005A-$95.86110.61%
2004A-$45.52-61.63%
2003A-$118.62186.67%
2002A-$41.38
2001N/A-100%
2000A-$33.10-63.64%
1999A-$91.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.55-577.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.57-463.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.09-141.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$3.74 42.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.82-169.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.59-274.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
A-$4.78 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA